台股 » 個股 » 醣聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

醣聯

(4168)
可現股當沖
  • 股價
    23.80
  • 漲跌
    ▼0.05
  • 漲幅
    -0.21%
  • 成交量
    109
  • 產業
    上櫃 生技醫療類股
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
醣聯 (4168)籌碼相關-台新-新莊 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台新-新莊 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/08124.6000.0024.6011590.63%
2024/12/1900.001026.1026.00-10162-6.16%
2024/12/1800.00125.8025.65-1157-0.63%
2024/12/05124.8000.0024.9011510.66%
2024/11/21025.0500.0024.9001690.00%
2024/11/191024.9200.0024.75101765.66%
2024/11/08125.4500.0025.3011940.51%
2024/10/2800.00427.0026.20-4234-1.71%
2024/10/2400.00126.0525.80-1243-0.41%
2024/10/08326.2000.0026.1533660.82%
2024/09/3000.00325.6025.50-3445-0.67%
2024/09/25125.5000.0025.4514860.21%
2024/09/18125.8000.0025.7517120.14%
2024/08/20127.6000.0027.3519000.11%
2024/08/07125.8500.0025.7018750.11%
2024/08/06224.0000.0024.8028710.23%
2024/08/01127.7500.0027.7018460.12%
2024/07/23130.3000.0029.6018170.12%
2024/07/11230.00129.8029.5017190.14%
2024/07/10230.3500.0030.4027130.28%
2024/07/0500.00530.0031.00-5692-0.72%
2024/07/0200.00229.9529.45-2714-0.28%
2024/06/2800.00231.0030.10-2679-0.29%
2024/06/27430.7600.0030.0046560.61%
2024/06/2600.00129.6030.65-1600-0.17%
2024/06/25129.3500.0029.0015530.18%
2024/06/2400.00328.5028.75-3496-0.60%
2024/06/1300.00226.5526.55-2443-0.45%
2024/06/0600.00127.0526.95-1430-0.23%
2024/06/05228.1500.0027.6524240.47%
2024/06/04527.3500.0027.5054301.16%
2024/06/03428.4300.0027.7544430.90%
2024/05/31327.3300.0028.2033740.80%
2024/05/30225.8500.0025.6523270.61%
2024/05/28125.5500.0025.5513240.31%
2024/05/27225.6000.0025.6023250.61%
2024/05/14025.2000.0025.3003250.00%
2024/05/130.425.0000.0024.950.43270.12%
2024/05/100.125.0000.0025.000.13270.03%
2024/05/07024.9500.0024.9003280.00%
2024/04/26125.6000.0025.5013270.31%
2024/04/2300.00125.3525.25-1327-0.31%
2024/04/11127.3000.0027.4013060.33%
2024/04/10228.1800.0028.0522930.68%
2024/04/09027.4500.0027.2502510.00%
2024/03/26324.7500.0024.6032611.15%
醣聯生物相似藥正式進入臨床三期 2026年Q2解盲Anue鉅亨-2024/12/17
醣聯完成生物相似藥一期試驗 Q4啟動三期臨床Anue鉅亨-2024/08/19
醣聯 相關文章
醣聯 相關影音